Previous studies have found no association between vaccination and MS in adults. To evaluate the association between ...

Biocon Biologics Ltd today announced that the European Medicines Agency's CHMP has issued a positive opinion recommending approval of YESINTEK®.

The Nimble acquisition, which follows the $1.4 billion buy of Aliada Therapeutics in October, will help AbbVie rebuild and ...

Mindera Health, a leader in precision medicine for dermatological conditions, today announced their participation in ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

Dr O'Donovan says psoriasis is not the only skin condition that can be a sign of high cholesterol. Xanthoma - waxy yellow ...

AbbVie has agreed a $200 million-plus takeover deal with Roche spinout Nimble Therapeutics that will give it control of a ...

The acquisition includes Nimble's investigational candidate, an oral peptide IL23R inhibitor to treat psoriasis.

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

The international collaborative HIPPOCRATES (Health initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European ...

Discover a study that showed that individuals with active psoriasis displayed a lower proportion of females and were more ...